From the Free Lance-Star:

The joint subcommittee heard a presentation from Carrie L. Wade, a drug abuse researcher who is director of harm-reduction policy at the R Street Institute, which bills itself as a free-market think tank.

Wade likened the use of reduced-harm tobacco products to programs that provide syringes to drug addicts as a way to reduce disease from shared needles and help them into drug treatment programs. She cited decreases in the sale of combustible tobacco products with the introduction of reduced-harm products in Japan, Sweden and the United Kingdom.